Akshat Jain: Key Takeaways from ASH2025: Transformative Therapeutics, Global Insight, and Compassionate Innovation
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:
“What an inspiring week at ASH2025 — the American Society of Hematology annual meeting in Orlando! Every year, this meeting reinforces why hematology is the beating heart of translational medicine. A few key takeaways that deeply resonated:

Transformative Therapeutics: The science behind novel agents continues to redefine how we treat human disease. The precision and creativity developed in blood disorders are now paving the way for breakthroughs across cancer, autoimmune, and metabolic diseases — a thrilling horizon for modern medicine.
Bench to Bedside in Action: Seeing how complex, chronic, and rare diseases are being approached with structured, risk-adapted protocols reminds me how rigor and compassion come together in true clinical innovation.
Industry: bouncing off ideas , laying Foundation for new collaborations and learning about pipeline always invigorate me.
Global Health Perspective: Hearing insights from colleagues across Europe, Asia, Africa, and beyond was humbling. The diversity in strategy, resource utilization, and patient response reminds us that innovation thrives when we listen, learn, and adapt globally.
Community and Collaboration: The best part — reconnecting with mentors, peers, and new collaborators. The exchange of ideas and the spark of potential partnerships always reignite my passion for research and patient care.

Grateful to be part of a field where discovery meets compassion every single day.
Thank you Andrea Fischer for keeping us informed and an amazing meeting.
Hemostasis Today, American Society of Clinical Oncology (ASCO), Blood Journals Portfolio bringing out timely reading.”
Stay updated with ASH25 updates with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis